Royalty Payments for Licensed Product Sample Clauses

Royalty Payments for Licensed Product. (a) In addition to those payments due to Checkpoint under 5.1 and 5.2 above, TGTX shall pay to Checkpoint a royalty at a rate of * percent (*%) on the Calendar Year, worldwide aggregate Net Sales of all Licensed Products during the Licensed Product-by-Licensed Product and country-by-country Royalty Terms by TGTX and its Affiliates and Sublicensees (but excluding Net Sales of a given Licensed Product in a given country after its applicable Royalty Term).
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
Royalty Payments for Licensed Product. (a) With respect to Net Sales of all Licensed Products: As further consideration for Licensor’s grant of the rights and licenses to Coronado hereunder, Coronado shall pay to Licensor a royalty on aggregate annual Net Sales of all such Licensed Products by Coronado and its Affiliates and Sublicensees (but excluding Net Sales of a given Licensed Product after its applicable Royalty Term), at the percentage rates set forth below: Annual Net Sales of Licensed Products per Calendar Year (US Dollars) Incremental Royalty Rate For that portion of aggregate annual Net Sales of all Licensed Products that is less than or equal to US$* *% For that portion of aggregate annual Net Sales of all Licensed Products that is greater than US$* and less than or equal to US$* *% For that portion of aggregate annual Net Sales of all Licensed Products that is greater than US$* *% * Confidential material redacted and filed separately with the Commission.
Sample 1Sample 2
Royalty Payments for Licensed Product. (other than Generic Product). As consideration for the rights granted pursuant to Section 2.1, Forest shall pay on a Licensed Product-by-Licensed Product basis for Licensed Product (other than Generic Product):
Sample 1
Royalty Payments for Licensed Product. (a) In addition to those payments due to Licensor under 5.1 and 5.2 above, Checkpoint shall pay to Licensor a tiered royalty on the Calendar Year, worldwide aggregate Net Sales of all Licensed Products during the Licensed Product-by-Licensed Product and country-by-country Royalty Terms by Checkpoint and its Affiliates and Sublicensees (but excluding Net Sales of a given Licensed Product in a given country after its applicable Royalty Term), at the percentage rates set forth below: Portion of Aggregate Calendar Year Net Sales of all Licensed Products (U.S. Dollars) Incremental Royalty Rate $* to $* * % More than $* to $* * % More than $* * % The thresholds in the above table shall be pro-rated for any Calendar Year in which the first Royalty Term commences or the last Royalty Term expires or terminates by multiplying such threshold (e.g., $500 million, $1 billion) by the number of days such Royalty Term was in effect during such Calendar Year and dividing the result by 365.
Sample 1
Royalty Payments for Licensed Product 
Sample 1Sample 2Sample 3See All (4)

Related to Royalty Payments for Licensed Product

  • Licensed Product “Licensed Product” shall mean any article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights. For clarity, a “Licensed Product” shall not include other product or material that (a) is used in combination with Licensed Product, and (b) does not constitute an article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Net Sales The term “

  • Marking of Licensed Products To the extent commercially feasible and consistent with prevailing business practices, Company shall xxxx, and shall cause its Affiliates and Sublicensees to xxxx, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that applies to such Licensed Product.

  • Royalty Term Licensee shall have no obligation to pay any royalty with respect to Net Sales of any Licensed Product in any country after the Royalty Term for such Licensed Product in such country has expired.

  • Know-How Royalty Notwithstanding the provisions of Section 5.4.1(a), in countries where the sale of Product by Merck or its Related Parties would not infringe a Valid Patent Claim, Merck shall pay royalty rates that shall be set at [***] of the applicable royalty rate determined according to Section 5.4.1(a). Such royalties shall be calculated after first calculating royalties under Section 5.4.1(a).

  • Royalty Payments (i) Royalties shall accrue when Licensed Products are invoiced, or if not invoiced, when delivered to a third party or Affiliate.

  • Licensed Territory Worldwide NIH Patent License Agreement—Exclusive APPENDIX C – ROYALTIES Royalties:

  • Royalty Payment In partial consideration of the grant of rights to Schering by ICN under this Agreement, Schering shall pay ICN a royalty in the following amount:

  • Royalty 8.1 In consideration of the rights granted under clause 2, the Licensee shall pay to the Licensor royalties, on each twelve month time period, first calculated from the date of execution of this Agreement, and calculated on a scale as follows:

Time is Money Join Law Insider Premium to draft better contracts faster.